Use of pan fgfr inhibitors and method of identifying patients with cancer eligible for treatment with a pan fgfr inhibitor

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

申请号：

IL25218717

公开号：

IL252187D0

申请日:

2017.05.09

申请国别(地区):

IL

年份:

2017

代理人:

摘要：

The current invention is based on a pan FGFR inhibitor for use in the treatment of cancer in a subject, wherein the subject is one for whom the sum of FGFR1, FGFR2 and/or FGFR3 mRNA in a tumor tissue sample from the subject has been found to be overexpressed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/